Apollomics APLM
NASDAQ APLM
$18.60 +0.35 (+1.92%)
As of: Nov 10, 2026 · 1:27 PM EST

Apollomics (APLM) Common Equity (2020 - 2025)

Updated

Apollomics (APLM) recorded Common Equity of -$3.2 million in Q4 2025, compared with $4.86 million a year earlier.

Analysis

Apollomics (APLM) Common Equity (2020 - 2025) Analysis & Trends

Starting with Q4 2021, Apollomics' Common Equity history includes 9 quarters.

  • Across earlier years, Common Equity came in at $4.86 million in FY2024 (-88.2%), $41.23 million in FY2023, -$448.12 million in FY2022 and -$212.86 million in FY2021.
  • Quarterly Common Equity has ranged from -$448.12 million in Q4 2022 to $55.7 million in Q2 2023 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 81.53 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -4.58 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 50.37 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 13.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 89.30 Bn
10 Apollomics 40.08 Mn -1.02 Mn - -3.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.20 Mn
Jun 30, 2025 -4.40 Mn
Dec 31, 2024 4.86 Mn
Jun 30, 2024 20.81 Mn
Dec 31, 2023 41.23 Mn
Jun 30, 2023 55.70 Mn
Dec 31, 2022 -448.12 Mn
Jun 30, 2022 -212.49 Mn
Dec 31, 2021 -212.86 Mn
Dec 31, 2020 -127.93 Mn
API Access

Apollomics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=APLM&period=max&api_key=YOUR_API_KEY